TY - JOUR
T1 - Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)
AU - JSMD Bipolar Disorder Guidelines Revision Working Group
AU - JSMD Bipolar Disorder Committee
AU - JSMD Guidelines Committee
AU - Kato, Tadafumi
AU - Ogasawara, Kazuyoshi
AU - Motomura, Keisuke
AU - Kato, Masaki
AU - Tanaka, Teruaki
AU - Takaesu, Yoshikazu
AU - Nio, Shintaro
AU - Kishi, Taro
AU - So, Mirai
AU - Nemoto, Kiyotaka
AU - Suzuki, Eiji
AU - Watanabe, Koichiro
AU - Matsuo, Koji
AU - Watanabe, Koichiro
AU - Kato, Tadafumi
AU - Matsuo, Koji
AU - Kamimura, Hisashi
AU - Okai, Hiroshi
AU - Shimode, Takaki
AU - Ogasawara, Kazuyoshi
AU - Kobayashi, Masato
AU - Kondo, Reo
AU - Takahara, Masaki
AU - Motomura, Keisuke
AU - Miura, Tomifumi
AU - Tanaka, Teruaki
AU - Nakato, Yasuya
AU - Toyoshima, Kuniyoshi
AU - Nio, Shintaro
AU - Tada, Mitsuhiro
AU - So, Mirai
AU - Sakai, Yoshie
AU - Sato, Jun
AU - Kitagawa, Nobuki
AU - Nakagawa, Atsuo
AU - Nemoto, Kiyotaka
AU - Watanabe, Naomi
AU - Kikuchi, Saya
AU - Ito, Kenji
AU - Yasuda, Takaki
AU - Suzuki, Eiji
AU - Yamada, Kazuo
AU - Usui, Keisuke
AU - Takahashi, Ai
AU - Watanabe, Norio
AU - Kato, Masaki
AU - Iga, Junichi
AU - Tajika, Aran
AU - Hori, Hikaru
AU - Ogata, Haruhiko
N1 - Publisher Copyright:
© 2024 The Author(s). Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
PY - 2024/11
Y1 - 2024/11
N2 - The Japanese Society of Mood Disorders (JSMD) published treatment guidelines of bipolar disorder in 2011. The present guidelines incorporating new findings were developed to comply to the guidelines of the National Academy of Medicine (NAM) by utilizing systematic reviews and meta-analysis and taking patient and family opinions as well as insights from multiple professional fields into account. They support combination therapy using mood stabilizers and second-generation antipsychotics in many aspects. They also have limitations, including the grouping of mood stabilizers and second-generation antipsychotics when meta-analysis was performed despite their distinct properties, due to the scarcity of drug-specific evidence. Despite the limitations, these guidelines provide clinical decision support for psychiatrists in Japan.
AB - The Japanese Society of Mood Disorders (JSMD) published treatment guidelines of bipolar disorder in 2011. The present guidelines incorporating new findings were developed to comply to the guidelines of the National Academy of Medicine (NAM) by utilizing systematic reviews and meta-analysis and taking patient and family opinions as well as insights from multiple professional fields into account. They support combination therapy using mood stabilizers and second-generation antipsychotics in many aspects. They also have limitations, including the grouping of mood stabilizers and second-generation antipsychotics when meta-analysis was performed despite their distinct properties, due to the scarcity of drug-specific evidence. Despite the limitations, these guidelines provide clinical decision support for psychiatrists in Japan.
KW - bipolar disorder
KW - meta-analysis
KW - pharmacotherapy
KW - psychosocial support
KW - systematic review
UR - https://www.scopus.com/pages/publications/85202538679
UR - https://www.scopus.com/pages/publications/85202538679#tab=citedBy
U2 - 10.1111/pcn.13724
DO - 10.1111/pcn.13724
M3 - Review article
C2 - 39194164
AN - SCOPUS:85202538679
SN - 1323-1316
VL - 78
SP - 633
EP - 645
JO - Psychiatry and Clinical Neurosciences
JF - Psychiatry and Clinical Neurosciences
IS - 11
ER -
SDG 3 すべての人に健康と福祉を